APA (7th ed.) Citation

Z, X., Y, C., S, D., X, H., Y, S., J, H., . . . M, D. (2026). HVT-based multiepitope vaccine administered subcutaneously or in ovo boosts protection of inactivated H9N2 vaccine against heterologous virus. Virologica Sinica, 41(2), 455. https://doi.org/10.1016/j.virs.2026.04.008

Chicago Style (17th ed.) Citation

Z, Xie, Chen Y, Du S, Huang X, Shao Y, Huang J, Liao M, and Dai M. "HVT-based Multiepitope Vaccine Administered Subcutaneously or in Ovo Boosts Protection of Inactivated H9N2 Vaccine Against Heterologous Virus." Virologica Sinica 41, no. 2 (2026): 455. https://doi.org/10.1016/j.virs.2026.04.008.

MLA (9th ed.) Citation

Z, Xie, et al. "HVT-based Multiepitope Vaccine Administered Subcutaneously or in Ovo Boosts Protection of Inactivated H9N2 Vaccine Against Heterologous Virus." Virologica Sinica, vol. 41, no. 2, 2026, p. 455, https://doi.org/10.1016/j.virs.2026.04.008.